Allopeptides and the alloimmune response

Cellular Immunology

Volumn 248, Issue 1, 2007, Pages 31-43

  Bharat, Ankit ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloimmune response; Allopeptides; MHC antigens; Regulatory T cells; Rejection; Tolerance

Indexed keywords

ALLOPEPTIDE; CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LIGAND BINDING; PATHOGENESIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MICE; MODELS, ANIMAL; PEPTIDES; RATS; RATS, INBRED LEW; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 36048980622     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.03.010     Document Type: Article

References (133)

1. Hernandez-Fuentes M.P., Baker R.J., and Lechler R.I. The alloresponse. Rev. Immunogenet. 1 3 (1999) 282
2. Game D.S., and Lechler R.I. Pathways of allorecognition: implications for transplantation tolerance. Transpl. Immunol. 10 2-3 (2002) 101
3. Sherman L.A., and Chattopadhyay S. The molecular basis of allorecognition. Annu. Rev. Immunol. 11 (1993) 385
4. Portoles P., Rojo J.M., and Janeway Jr. C.A. Asymmetry in the recognition of antigen: self class II MHC and non-self class II MHC molecules by the same T-cell receptor. J. Mol. Cell. Immunol. 4 3 (1989) 129
5. Kourilsky P., Chaouat G., Rabourdin-Combe C., and Claverie J.M. Working principles in the immune system implied by the "peptidic self" model. Proc. Natl. Acad. Sci. USA 84 10 (1987) 3400
6. Matzinger P., and Bevan M.J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?. Cell. Immunol. 29 1 (1977) 1
7. Lafferty K.J., Bootes A., Dart G., and Talmage D.W. Effect of organ culture on the survival of thyroid allografts in mice. Transplantation 22 2 (1976) 138
8. Lechler R.I., and Batchelor J.R. Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient. J. Exp. Med. 156 6 (1982) 1835
9. Lechler R.I., and Batchelor J.R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155 1 (1982) 31
10. Pietra B.A., Wiseman A., Bolwerk A., Rizeq M., and Gill R.G. CD4T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J. Clin. Invest. 106 8 (2000) 1003
11. Inaba K., Pack M., Inaba M., Sakuta H., Isdell F., and Steinman R.M. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186 5 (1997) 665
12. Murphy D.B., Lo D., Rath S., et al. A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature 338 6218 (1989) 765
13. Fangmann J., Dalchau R., and Fabre J.W. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med. 175 6 (1992) 1521
14. Fangmann J., Dalchau R., Sawyer G.J., Priestley C.A., and Fabre J.W. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur. J. Immunol. 22 6 (1992) 1525
15. Auchincloss Jr. H., Lee R., Shea S., Markowitz J.S., Grusby M.J., and Glimcher L.H. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90 8 (1993) 3373
16. Moron G., Dadaglio G., and Leclerc C. New tools for antigen delivery to the MHC class I pathway. Trends Immunol. 25 2 (2004) 92
17. Heeger P.S. T-cell allorecognition and transplant rejection: a summary and update. Am. J. Transplant. 3 5 (2003) 525
18. Benichou G., Valujskikh A., and Heeger P.S. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J. Immunol. 162 1 (1999) 352
19. Lindahl K.F., and Wilson D.B. Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J. Exp. Med. 145 3 (1977) 508
20. Suchin E.J., Langmuir P.B., Palmer E., Sayegh M.H., Wells A.D., and Turka L.A. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166 2 (2001) 973
21. Sawyer G.J., Dalchau R., and Fabre J.W. Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transpl. Immunol. 1 1 (1993) 77
22. + cytolytic T lymphocytes. Hum. Immunol. 46 1 (1996) 1
23. Chen B.P., Madrigal A., and Parham P. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J. Exp. Med. 172 3 (1990) 779
24. + alloreactive T lymphocyte clone. J. Exp. Med. 172 1 (1990) 387
25. Vella J.P., Spadafora-Ferreira M., Murphy B., et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 64 6 (1997) 795
26. Liu Z., Colovai A.I., Tugulea S., et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J. Clin. Invest. 98 5 (1996) 1150
27. Bharat A., Narayanan K., Street T., et al. Early post-transplant inflammation promotes the development of alloimmunity and chronic human allograft rejection. Transplantation 83 2 (2007) 150
28. Sharrow S.O., Mathieson B.J., and Singer A. Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras. J. Immunol. 126 4 (1981) 1327
29. Huang J.F., Yang Y., Sepulveda H., et al. TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science 286 5441 (1999) 952
30. + T cells involving acquired MHC class II: peptide complexes: another mechanism to limit clonal expansion?. Blood 101 7 (2003) 2704
31. Andre F., Chaput N., Schartz N.E., et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172 4 (2004) 2126
32. Bedford P., Garner K., and Knight S.C. MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions. Int. Immunol. 11 11 (1999) 1739
33. + T cells by dendritic cell-derived exosomes. Nat. Immunol. 3 12 (2002) 1156
34. Jiang S., Herrera O., and Lechler R.I. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr. Opin. Immunol. 16 5 (2004) 550
35. Elliott T.J., and Eisen H.N. Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc. Natl. Acad. Sci. USA 87 13 (1990) 5213
36. Jankovic V., Remus K., Molano A., and Nikolich-Zugich J. T cell recognition of an engineered MHC class I molecule: implications for peptide-independent alloreactivity. J. Immunol. 169 4 (2002) 1887
37. Smith P.A., Brunmark A., Jackson M.R., and Potter T.A. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL). J. Exp. Med. 185 6 (1997) 1023
38. Jaramillo A., Fernandez F.G., Kuo E.Y., Trulock E.P., Patterson G.A., and Mohanakumar T. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr. Transplant. 9 1 (2005) 84
39. SivaSai K.S., Smith M.A., Poindexter N.J., et al. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation 67 8 (1999) 1094
40. Lu K.C., Jaramillo A., Mendeloff E.N., et al. Concomitant allorecognition of mismatched donor HLA class I- and class II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 22 1 (2003) 35
41. Goulmy E. Human minor histocompatibility antigens. Curr. Opin. Immunol. 8 1 (1996) 75
42. Mayer T.G., Bhan A.K., and Winn H.J. Immunohistochemical analyses of skin graft rejection in mice. Kinetics of lymphocyte infiltration in grafts of limited immunogenetic disparity. Transplantation 46 6 (1988) 890
43. Watarai Y., Koga S., Paolone D.R., et al. Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts. J. Immunol. 164 11 (2000) 6027
44. Koulack J., McAlister V.C., MacAulay M.A., Bitter-Suermann H., MacDonald A.S., and Lee T.D. Importance of minor histocompatibility antigens in the development of allograft arteriosclerosis. Clin. Immunol. Immunopathol. 80 3 Pt 1 (1996) 273
45. + T cells in murine skin and heart allograft rejection across different antigenic desparities. Transpl. Immunol. 13 4 (2004) 297
46. Karnovsky M.J., Russell M.E., Hancock W., Sayegh M.H., and Adams D.H. Chronic rejection in experimental cardiac transplantation in a rat model. Clin. Transplant. 8 3 Pt 2 (1994) 308
47. Poindexter N., Shenoy S., Howard T., Flye M.W., and Mohanakumar T. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens. Clin. Transplant. 11 3 (1997) 174
48. + cytotoxic T cells. Transplantation 76 1 (2003) 84
49. + CTLs recognizing a single minor histocompatibility antigen. J. Immunol. 174 4 (2005) 1871
50. Demotz S., Sette A., Sakaguchi K., Buchner R., Appella E., and Grey H.M. Self peptide requirement for class II major histocompatibility complex allorecognition. Proc. Natl. Acad. Sci. USA 88 19 (1991) 8730
51. Lombardi G., Sidhu S., Batchelor J.R., and Lechler R.I. Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. USA 86 11 (1989) 4190
52. Marrack P., and Kappler J. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature 332 6167 (1988) 840
53. Heath W.R., Hurd M.E., Carbone F.R., and Sherman L.A. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature 341 6244 (1989) 749
54. Malarkannan S., Afkarian M., and Shastri N. A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. J. Exp. Med. 182 6 (1995) 1739
55. Crotzer V.L., and Blum J.S. Autophagy and intracellular surveillance: modulating MHC class II antigen presentation with stress. Proc. Natl. Acad. .Sci. USA 102 22 (2005) 7779
56. Dengjel J., Schoor O., Fischer R., et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl. Acad. Sci. USA 102 22 (2005) 7922
57. Fedoseyeva E.V., Zhang F., Orr P.L., Levin D., Buncke H.J., and Benichou G. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J. Immunol. 162 11 (1999) 6836
58. + T cells in cardiac transplant patients. Transplantation 77 10 (2004) 1604
59. + regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am. J. Transplant. 6 8 (2006) 1799
60. + regulatory T cells through CTLA-4 signaling. J. Immunol. 177 8 (2006) 5631
61. Haque M.A., Mizobuchi T., Yasufuku K., et al. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J. Immunol. 169 3 (2002) 1542
62. Birk O.S., Gur S.L., Elias D., et al. The 60-kDa heat shock protein modulates allograft rejection. Proc. Natl. Acad. Sci. USA 96 9 (1999) 5159
63. Jaramillo A., Naziruddin B., Zhang L., et al. Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome. Transplantation 71 7 (2001) 966
64. Carter V., Shenton B.K., Jaques B., et al. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant. Proc. 37 2 (2005) 654
65. Le Bas-Bernardet S., Hourmant M., Coupel S., Bignon J.D., Soulillou J.P., and Charreau B. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am. J. Transplant. 3 2 (2003) 167
66. Dragun D., Muller D.N., Brasen J.H., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N. Engl. J. Med. 352 6 (2005) 558
67. Garcia K.C., Tallquist M.D., Pease L.R., et al. Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc. Natl. Acad. Sci. USA 94 25 (1997) 13838
68. Reiser J.B., Darnault C., Gregoire C., et al. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 4 3 (2003) 241
69. Reiser J.B., Darnault C., Guimezanes A., et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat. Immunol. 1 4 (2000) 291
70. Sha W.C., Nelson C.A., Newberry R.D., Kranz D.M., Russell J.H., and Loh D.Y. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336 6194 (1988) 73
71. Rudolph M.G., and Wilson I.A. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14 1 (2002) 52
72. Stewart-Jones G.B., McMichael A.J., Bell J.I., Stuart D.I., and Jones E.Y. A structural basis for immunodominant human T cell receptor recognition. Nat. Immunol. 4 7 (2003) 657
73. Luz J.G., Huang M., Garcia K.C., et al. Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions. J. Exp. Med. 195 9 (2002) 1175
74. Hennecke J., and Wiley D.C. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 195 5 (2002) 571
75. Reiser J.B., Gregoire C., Darnault C., et al. A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16 3 (2002) 345
76. Dyall R., Fremont D.H., Jameson S.C., and Nikolic-Zugic J. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation. J. Exp. Med. 184 1 (1996) 253
77. Larsen C.P., Steinman R.M., Witmer-Pack M., Hankins D.F., Morris P.J., and Austyn J.M. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172 5 (1990) 1483
78. Lakkis F.G., Arakelov A., Konieczny B.T., and Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6 6 (2000) 686
79. Zhou P., Hwang K.W., Palucki D., et al. Secondary lymphoid organs are important but not absolutely required for allograft responses. Am. J. Transplant. 3 3 (2003) 259
80. Kreisel D., Krupnick A.S., Gelman A.E., et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat. Med. 8 3 (2002) 233
81. Morita K., Miura M., Paolone D.R., et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J. Immunol. 167 5 (2001) 2979
82. el-Sawy T., Fahmy N.M., and Fairchild R.L. Chemokines: directing leukocyte infiltration into allografts. Curr. Opin. Immunol. 14 5 (2002) 562
83. Smith C.R., Jaramillo A., Duffy B.F., and Mohanakumar T. Airway epithelial cell damage mediated by antigen-specific T cells: implications in lung allograft rejection. Hum. Immunol. 61 10 (2000) 985
84. Mauck K.A., and Hosenpud J.D. The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation. J. Heart Lung Transplant. 15 7 (1996) 709
85. Nakajima J., Ono M., Takeda M., Kawauchi M., Furuse A., and Takizawa H. Role of costimulatory molecules on airway epithelial cells acting as alloantigen-presenting cells. Transplant. Proc. 29 4 (1997) 2297
86. Mandelbrot D.A., Kishimoto K., Auchincloss Jr. H., Sharpe A.H., and Sayegh M.H. Rejection of mouse cardiac allografts by costimulation in trans. J. Immunol. 167 3 (2001) 1174
87. Sayegh M.H., Perico N., Imberti O., Hancock W.W., Carpenter C.B., and Remuzzi G. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 56 2 (1993) 461
88. Binder J., Sayegh M.H., Watschinger B., Hancock W.W., and Kupiec-Weglinski J.W. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats. Transplantation 58 1 (1994) 80
89. Chowdhury N.C., Jin M.X., Hardy M.A., and Oluwole S.F. Donor-specific unresponsiveness to murine cardiac allografts induced by intrathymic-soluble alloantigens is dependent on alternate pathway of antigen presentation. J. Surg. Res. 59 1 (1995) 91
90. Ohajekwe O.A., Chowdhury N.C., Fiedor P.S., Hardy M.A., and Oluwole S.F. Transplantation tolerance to rat cardiac and islet allografts by posttransplant intrathymic inoculation of soluble alloantigens. Transplantation 60 10 (1995) 1139
91. Oluwole O.O., Depaz H.A., Gopinathan R., et al. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 50 7 (2001) 1546
92. Oluwole S.F., Chowdhury N.C., Jin M.X., and Hardy M.A. Induction of transplantation tolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides. Transplantation 56 6 (1993) 1523
93. Shimomura K., Hardy M.A., and Oluwole S.F. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Transplantation 60 8 (1995) 806
94. Shimomura K., Hardy M.A., and Oluwole S.F. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival. Transplant. Proc. 27 1 (1995) 127
95. Goss J.A., Nakafusa Y., Finke E.H., Flye M.W., and Lacy P.E. Induction of tolerance to islet xenografts in a concordant rat-to-mouse model. Diabetes 43 1 (1994) 16
96. Goss J.A., Nakafusa Y., Uchiyama K., and Flye M.W. Induction of extended survival of rat skin xenografts in mice by pretreatment with intrathymic xenoantigen and antilymphocyte serum. Transplantation 54 6 (1992) 1101
97. Nakafusa Y., Goss J.A., and Flye M.W. Prevention by thymectomy of tolerance induced by intrathymic injection of donor splenocytes. Surgery 114 2 (1993) 183
98. Goss J.A., Nakafusa Y., and Flye M.W. MHC class II presenting cells are necessary for the induction of intrathymic tolerance. Ann. Surg. 217 5 (1993) 492
99. Goss J.A., Nakafusa Y., Yu S., and Flye M.W. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection. Transplant. Proc. 25 1 Pt 1 (1993) 286
100. Goss J.A., Nakafusa Y., and Flye M.W. Donor-specific cardiac allograft tolerance without immunosuppression after intrathymic injection of donor alloantigen. Transplant. Proc. 24 6 (1992) 2879
101. Goss J.A., Nakafusa Y., and Flye M.W. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression. Ann. Surg. 216 4 (1992) 409
102. Takayashiki T., Asakura H., Ku G., Kataoka M., and Flye M.W. Infectious tolerance develops after intrathymic alloantigen-induced acceptance of rat heart allografts can be adoptively transferred. Surgery 138 2 (2005) 254
103. + regulatory T cells. Transplant. Proc. 37 1 (2005) 40
104. + Treg cells. Transplantation 79 11 (2005) 1492
105. Stadlbauer T.H., Schaub M., Magee C.C., Kupiec-Weglinski J.W., and Sayegh M.H. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways. J. Heart Lung Transplant. 19 6 (2000) 566
106. Ali A., Garrovillo M., Oluwole O.O., et al. Mechanisms of acquired thymic tolerance: induction of transplant tolerance by adoptive transfer of in vivo allomhc peptide activated syngeneic T cells. Transplantation 71 10 (2001) 1442
107. Faria A.M., and Weiner H.L. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73 (1999) 153
108. H.G. Wells. Studies on the chemistry of anaphylaxis III. Experiments with isolated proteins, specially those of the hen's eff. J. Infect. Dis. 8 (1911) 147.
109. Sayegh M.H., Zhang Z.J., Hancock W.W., Kwok C.A., Carpenter C.B., and Weiner H.L. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation 53 1 (1992) 163
110. Hancock W.W., Sayegh M.H., Zhang Z.J., Kwok C.A., Weiner H.L., and Carpenter C.B. Oral immunization with allogeneic splenocytes inhibits development of accelerated but not acute rejection of cardiac grafts: analysis of intragraft effector mechanisms. Transplant. Proc. 24 1 (1992) 250
111. Wang M., Stepkowski S.M., Yu J., Wang M., and Kahan B.D. Localization of cryptic tolerogenic epitopes in the alpha1-helical region of the RT1. Au alloantigen. Transplantation 63 10 (1997) 1373
112. Stepkowski S.M., Wang M., Langowski J., et al. Localization of tolerogenic epitopes in the alpha 1 helical region of the rat class I major histocompatibility complex molecule. Transplant. Proc. 29 3 (1997) 1663
113. Stepkowski S.M., Yu J., Wang M., and Kahan B.D. Induction of tolerance by oral administration of a tolerogenic allochimeric donor/recipient class I MHC protein. Transplant. Proc. 31 3 (1999) 1557
114. Yasufuku K., Heidler K.M., O'Donnell P.W., et al. Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am. J. Respir. Cell. Mol. Biol. 25 1 (2001) 26
115. Dettino A.L., Duarte A.J., and Sato M.N. Induction of oral tolerance and the effect of interleukin-4 on murine skin allograft rejection. Braz. J. Med. Biol. Res. 37 3 (2004) 435
116. Ishido N., Matsuoka J., Matsuno T., Nakagawa K., and Tanaka N. Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes. Transplantation 68 9 (1999) 1377
117. Evavold B.D., and Allen P.M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252 5010 (1991) 1308
118. Sloan-Lancaster J., Evavold B.D., and Allen P.M. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363 6425 (1993) 156
119. Evavold B.D., Sloan-Lancaster J., Hsu B.L., and Allen P.M. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150 8 Pt 1 (1993) 3131
120. Colovai A.I., Liu Z., Harris P.E., Cortesini R., and Suciu-Foca N. Allopeptide-specific T cell reactivity altered by peptide analogs. J. Immunol. 158 1 (1997) 48
121. Sloan-Lancaster J., and Allen P.M. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14 (1996) 1
122. Bharat A., Fields R.C., and Mohanakumar T. Regulatory T cell-mediated transplantation tolerance. Immunol. Res. 33 3 (2005) 195
123. Dieckmann D., Bruett C.H., Ploettner H., Lutz M.B., and Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J. Exp. Med. 196 2 (2002) 247
124. Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J., and Enk A.H. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. 196 2 (2002) 255
125. Sanchez-Fueyo A., Weber M., Domenig C., Strom T.B., and Zheng X.X. Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 168 5 (2002) 2274
126. Graca L., Thompson S., Lin C.Y., Adams E., Cobbold S.P., and Waldmann H. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168 11 (2002) 5558
127. + regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J. Immunol. 175 1 (2005) 32
128. Furtado G.C., Curotto de Lafaille M.A., Kutchukhidze N., and Lafaille J.J. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196 6 (2002) 851
129. Smith C.R., Mohanakumar T., Shimizu Y., et al. Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model. Transplantation 69 2 (2000) 294
130. Sakaguchi S., and Sakaguchi N. Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice. J. Exp. Med. 167 4 (1988) 1479
131. + T cells in peripheral blood after liver transplantation: association with immunosuppression. Transplant. Proc. 37 2 (2005) 1194
132. Ciancio G., Burke G.W., Gaynor J.J., et al. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring1. Transplantation 80 4 (2005) 457
133. Khalifah A.P., Hachem R.R., Chakinala M.M., et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am. J. Respir. Crit. Care Med. 170 2 (2004) 181